Previously, we have identified the sequential activation of reactive oxygen species (ROS), mitochondria, and caspase-3, -8 and -9, in Siglec-8-mediated eosinophil apoptosis. Cytokine priming, which normally prolongs eosinophil survival, paradoxically potentiated this proapoptotic effect. The mechanisms of Siglec-8-mediated apoptosis after priming were therefore explored. Using interleukin-5 (IL-5) as the priming stimulus, the rate of Siglec-8-induced eosinophil apoptosis was found to be enhanced compared to unprimed cells, and mechanisms differed after IL-5 priming in that neither a pan-caspase inhibitor, nor a specific caspase-3 inhibitor, could override apoptosis. IL-5 priming also accelerated Siglec-8-mediated dissipation of mitochondrial membrane potential (m). Finally, both the mitochondrial electron transport inhibitor rotenone, and the reactive oxygen species (ROS) inhibitors diphenyleneiodonium (DPI) and antimycin, completely inhibited Siglec-8-mediated apoptosis, even after IL-5 priming. These data demonstrate that IL-5 priming enhances Siglec-8 mediated mitochondrial and ROS-dependent eosinophil apoptosis and eliminates caspase dependency. The potential clinical implication of these findings is that cytokine priming, as often occurs in vivo in asthma and other hypereosinophilic disorders, may render eosinophils from such patients especially susceptible to the proapoptotic effects of a Siglec-8-engaging therapeutic agent.